In our series, overexpression of ET-1, ETBR and especially of ETAR was associated with clinicopathological parameters that characterise aggressive types of breast cancer and indicated a poor outcome, whereas other studies failed to confirm such correlations. Here, EDNRB is linked to breast cancer.